Grifols, S.A. recently announced that they have expanded their commitment of humanitarian product donations to the World Federation of Hemophilia (WFH). Specifically, the company will donate a minimum of 140 million international units (IU) of plasma-derived clotting factor VIII (FVIII) to the WFH Humanitarian Aid Program over the next five years.
The announcement, made to coincide with World Hemophilia Day, signifies a continuation of a commitment Grifols made to WFH in 2014. The company’s total humanitarian aid commitment to the program is now more than 200 million IUs of FVIII over a span of eight years.
“Today, World Hemophilia Day represents ideal timing for Grifols to reaffirm our long-standing commitment to bleeding disorders and the hemophilia community,” said Victor Grifols Roura, President of Grifols. “Our philosophy aligns fully with the mission of WFH, sharing a clear passion for providing adequate treatment for all patients regardless of where they live.”
Source: Grifols new release dated April 17, 2017
